HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

YM348

5-HT2C receptor agonist & an antiobesity drug

Also Known As:

(S)-2-(7-ethyl-1H-furo(2,3-g)indazol-1-yl)-1-methylethylamine

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - Indazoles: 179
        YM348: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indazoles: 179
      - YM348: 2

Experts

1.	Ito, Hiroyuki: 1 article (07/2013)
2.	Nagakura, Yukinori: 1 article (07/2013)
3.	Oe, Tomoya: 1 article (07/2013)
4.	Ogino, Shinichi: 1 article (07/2013)
5.	Ozawa, Tohru: 1 article (07/2013)
6.	Shimizu, Yasuaki: 1 article (07/2013)
7.	Tsukamoto, Mina: 1 article (07/2013)
8.	Watabiki, Tomonari: 1 article (07/2013)
9.	Hayashi, Aska: 1 article (06/2004)
10.	Kimura, Yasuharu: 1 article (06/2004)

Related Diseases

1.	Schizophrenia (Dementia Praecox) 07/01/2013 - "Three 5-HT(2C) receptor agonists (lorcaserin, vabicaserin and YM348) that have been suggested to be useful in the treatment of several central nervous system diseases, including obesity and schizophrenia, were used. "
2.	Obesity 07/01/2013 - "Three 5-HT(2C) receptor agonists (lorcaserin, vabicaserin and YM348) that have been suggested to be useful in the treatment of several central nervous system diseases, including obesity and schizophrenia, were used. "
3.	Central Nervous System Diseases (CNS Diseases) 07/01/2013 - "Three 5-HT(2C) receptor agonists (lorcaserin, vabicaserin and YM348) that have been suggested to be useful in the treatment of several central nervous system diseases, including obesity and schizophrenia, were used. "
4.	Body Weight (Weight, Body) 06/18/2004 - "These results suggest that the maintenance of thermogenesis contributed to the reduced body weight by YM348. " 06/18/2004 - "Two weeks' subcutaneous infusion of YM348 (3 and 30 mg/kg/day) resulted in a significant decrease in body weight gain throughout the experiment. " 06/18/2004 - "The ability of YM348 to decrease body weight in Zucker rats suggests its strong potential for development as an antiobesity agent in humans."

Related Drugs and Biologics

1.	5-HT2C Serotonin Receptor
2.	vabicaserin
3.	lorcaserin
4.	Anti-Obesity Agents (Antiobesity Drugs)

Related Therapies and Procedures

1.	Subcutaneous Infusions